tirzepatide and psoriatic arthritis Concomitant ixekizumab significantly improved disease activity and promoted weight reduction versus ixekizumab alone in adults with PsA and obesity or overweight in the TOGETHER-PsA phase 3b trial. Read Lilly's Taltz Plus Zepbound Delivers

While this test identifies your genetic predispositions to GLP-1 response, it doesn't predict medication shelf lifebut it does help personalize your treatment protocol for optimal results

Llorente-Berzal A, Puighermanal E, Burokas A, Ozaita A, Maldonado R, Marco EM, et al

Tirzepatide is a firstinclass glucosedependent insulinotropic polypeptide and glucagonlike peptide1 receptor agonist once weekly injectable approved for the treatment of type 2 diabetes mellitus and is currently in phase III development for chronic weight management

The pharmacy sourcing is named (Epiq Scripts, a state-licensed 503A compounder), one of the few programs that publicly cites its dispensing pharmacy by name rather than obscuring it behind a licensed partner network phrase

If you are a woman comparing these two options, the relevant comparison is Hers vs Mochi Health rather than Hims